Cargando…
Midodrine to optimize heart failure therapy in patients with concurrent hypotension
According to the Centers for Disease Control and Prevention statistics, about 6.2 million adults in the United States have heart failure. Guideline-Directed Medical Therapy (GDMT) involving the use of renin-angiotensin-aldosterone system inhibitors with or without a neprilysin inhibitor, β-blockers,...
Autores principales: | Shiu, Paul, Grewal, Gurinder S, Kozik, Teri M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121496/ https://www.ncbi.nlm.nih.gov/pubmed/35601610 http://dx.doi.org/10.1177/2050313X221100400 |
Ejemplares similares
-
Midodrine for orthostatic hypotension
Publicado: (2020) -
Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist’s proposal: a case report
por: Asai, Yuki, et al.
Publicado: (2021) -
Management of Hypotension and Bradycardia Caused By Spinal Cord Injury. The Usefulness of Midodrine and Methylxanthines
por: Mojtahedzadeh, Mojtaba, et al.
Publicado: (2019) -
Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Publicado: (2020) -
Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
por: Byun, Jung‐Ick, et al.
Publicado: (2019)